Cargando…
Role of ERK Pathway in the Pathogenesis of Atopic Dermatitis and Its Potential as a Therapeutic Target
Atopic dermatitis (AD) is an eczematous skin disorder characterized by type 2 inflammation, barrier disruption, and intense itch. In addition to type 2 cytokines, many other cytokines, such as interferon gamma (IFN-γ), interleukin 17 (IL-17), and interleukin 22 (IL-22), play roles in the pathogenesi...
Autores principales: | Zeze, Nahoko, Kido-Nakahara, Makiko, Tsuji, Gaku, Maehara, Eriko, Sato, Yuki, Sakai, Sawako, Fujishima, Kei, Hashimoto-Hachiya, Akiko, Furue, Masutaka, Nakahara, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999015/ https://www.ncbi.nlm.nih.gov/pubmed/35408826 http://dx.doi.org/10.3390/ijms23073467 |
Ejemplares similares
-
Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
por: Furue, Masutaka, et al.
Publicado: (2019) -
Glyteer, Soybean Tar, Impairs IL-4/Stat6 Signaling in Murine Bone Marrow-Derived Dendritic Cells: The Basis of Its Therapeutic Effect on Atopic Dermatitis
por: Takemura, Masaki, et al.
Publicado: (2018) -
The EGFR-ERK/JNK-CCL20 Pathway in Scratched Keratinocytes May Underpin Koebnerization in Psoriasis Patients
por: Furue, Kazuhisa, et al.
Publicado: (2020) -
Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes
por: Ulzii, Dugarmaa, et al.
Publicado: (2019) -
Topical application of endothelin receptor a antagonist attenuates imiquimod-induced psoriasiform skin inflammation
por: Nakahara, Takeshi, et al.
Publicado: (2020)